HomeCompareTEEAX vs JNJ

TEEAX vs JNJ: Dividend Comparison 2026

TEEAX yields 100.04% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TEEAX wins by $3.88M in total portfolio value
10 years
TEEAX
TEEAX
● Live price
100.04%
Share price
$11.46
Annual div
$11.46
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.90M
Annual income
$1,315,615.89
Full TEEAX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — TEEAX vs JNJ

📍 TEEAX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTEEAXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TEEAX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TEEAX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TEEAX
Annual income on $10K today (after 15% tax)
$8,503.63/yr
After 10yr DRIP, annual income (after tax)
$1,118,273.51/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, TEEAX beats the other by $1,117,569.89/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TEEAX + JNJ for your $10,000?

TEEAX: 50%JNJ: 50%
100% JNJ50/50100% TEEAX
Portfolio after 10yr
$1.96M
Annual income
$658,221.83/yr
Blended yield
33.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

TEEAX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TEEAX buys
0
JNJ buys
0
No recent congressional trades found for TEEAX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTEEAXJNJ
Forward yield100.04%3.36%
Annual dividend / share$11.46$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$3.90M$20.0K
Annual income after 10y$1,315,615.89$827.78
Total dividends collected$3.48M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: TEEAX vs JNJ ($10,000, DRIP)

YearTEEAX PortfolioTEEAX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$20,704$10,004.28$10,676$355.77+$10.0KTEEAX
2$41,512$19,358.06$11,407$389.39+$30.1KTEEAX
3$80,691$36,273.38$12,198$426.53+$68.5KTEEAX
4$152,235$65,895.92$13,056$467.62+$139.2KTEEAX
5$279,081$116,189.09$13,987$513.12+$265.1KTEEAX
6$497,682$199,065.73$14,998$563.56+$482.7KTEEAX
7$864,288$331,768.34$16,098$619.52+$848.2KTEEAX
8$1,463,254$538,465.33$17,295$681.69+$1.45MTEEAX
9$2,417,672$851,991.05$18,599$750.82+$2.40MTEEAX
10$3,902,525$1,315,615.89$20,022$827.78+$3.88MTEEAX

TEEAX vs JNJ: Complete Analysis 2026

TEEAXStock

The fund normally invests at least 80% of its assets in common stocks of small companies. The adviser currently considers small companies to be those within the market capitalization range of the Russell 2000® Index at the time of initial purchase by the fund. As part of the investment process, the Advisor takes environmental, social and governance (“ESG”) factors into account through an integrated approach within the investment team’s fundamental investment analysis framework.

Full TEEAX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this TEEAX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TEEAX vs SCHDTEEAX vs JEPITEEAX vs OTEEAX vs KOTEEAX vs MAINTEEAX vs ABBVTEEAX vs MRKTEEAX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.